Latest Insider Transactions at Anebulo Pharmaceuticals, Inc. (ANEB)
This section provides a real-time view of insider transactions for Anebulo Pharmaceuticals, Inc. (ANEB). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Anebulo Pharmaceuticals, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Anebulo Pharmaceuticals, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 18
2023
|
Aron R. English Director |
BUY
Bona fide gift
|
Indirect |
300,000
+5.29%
|
-
|
Dec 18
2023
|
Aron R. English Director |
SELL
Bona fide gift
|
Indirect |
300,000
-100.0%
|
-
|
Nov 13
2023
|
Aron R. English Director |
BUY
Grant, award, or other acquisition
|
Indirect |
300,000
+50.0%
|
-
|
Sep 28
2022
|
Aron R. English Director |
BUY
Grant, award, or other acquisition
|
Indirect |
1,703,577
+25.16%
|
$3,407,154
$2.81 P/Share
|
Dec 17
2021
|
Aron R. English Director |
BUY
Open market or private purchase
|
Indirect |
400
+0.01%
|
$2,400
$6.59 P/Share
|
Dec 14
2021
|
Aron R. English Director |
BUY
Open market or private purchase
|
Indirect |
412
+0.01%
|
$2,060
$5.89 P/Share
|
Dec 03
2021
|
Aron R. English Director |
BUY
Open market or private purchase
|
Indirect |
4,500
+0.13%
|
$22,500
$5.93 P/Share
|
Dec 02
2021
|
Aron R. English Director |
BUY
Open market or private purchase
|
Indirect |
13,836
+0.41%
|
$69,180
$5.3 P/Share
|
May 06
2021
|
Aron R. English Director |
BUY
Grant, award, or other acquisition
|
Indirect |
714,286
+17.6%
|
$5,000,002
$7.0 P/Share
|